Cargando…

Commercial SARS-CoV-2 Targeted, Protease Inhibitor Focused and Protein–Protein Interaction Inhibitor Focused Molecular Libraries for Virtual Screening and Drug Design

Since December 2019, the new SARS-CoV-2-related COVID-19 disease has caused a global pandemic and shut down the public life worldwide. Several proteins have emerged as potential therapeutic targets for drug development, and we sought out to review the commercially available and marketed SARS-CoV-2-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kralj, Sebastjan, Jukič, Marko, Bren, Urban
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745317/ https://www.ncbi.nlm.nih.gov/pubmed/35008818 http://dx.doi.org/10.3390/ijms23010393

Ejemplares similares

Design of Tetra-Peptide Ligands of Antibody Fc Regions Using In Silico Combinatorial Library Screening
por: Jukič, Marko, et al.
Publicado: (2023)

Comparative Analyses of Medicinal Chemistry and Cheminformatics Filters with Accessible Implementation in Konstanz Information Miner (KNIME)
por: Kralj, Sebastjan, et al.
Publicado: (2022)

Novel Small-Molecule Inhibitors of the SARS-CoV-2 Spike Protein Binding to Neuropilin 1
por: Kolarič, Anja, et al.
Publicado: (2022)

Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations
por: Jukič, Marko, et al.
Publicado: (2021)

Ensemble Docking Coupled to Linear Interaction Energy Calculations for Identification of Coronavirus Main Protease (3CL(pro)) Non-Covalent Small-Molecule Inhibitors
por: Jukič, Marko, et al.
Publicado: (2020)

Prioritisation of Compounds for 3CL(pro) Inhibitor Development on SARS-CoV-2 Variants
por: Jukič, Marko, et al.
Publicado: (2021)

Discovery of Inhibitors of Trypanosoma brucei by Phenotypic Screening of a Focused Protein Kinase Library
por: Woodland, Andrew, et al.
Publicado: (2015)

Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library
por: Dawadi, Surendra, et al.
Publicado: (2020)

Identifying Metal Binding Sites in Proteins Using Homologous Structures, the MADE Approach
por: Ravnik, Vid, et al.
Publicado: (2023)

Naive Prediction of Protein Backbone Phi and Psi Dihedral Angles Using Deep Learning
por: Broz, Matic, et al.
Publicado: (2023)

Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints
por: Jukič, Marko, et al.
Publicado: (2021)

Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods
por: Reynès, Christelle, et al.
Publicado: (2010)

Mechanistic Insights of Polyphenolic Compounds from Rosemary Bound to Their Protein Targets Obtained by Molecular Dynamics Simulations and Free-Energy Calculations
por: Lešnik, Samo, et al.
Publicado: (2023)

Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors
por: Langdon, Sarah R., et al.
Publicado: (2013)

Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy
por: Srikanth, Sandhya, et al.
Publicado: (2016)

Virtual screening and molecular dynamics simulation study of plant protease inhibitors against SARS-CoV-2 envelope protein
por: Kirar, Manisha, et al.
Publicado: (2022)

Identification of non-covalent SARS-CoV-2 main protease inhibitors by a virtual screen of commercially available drug-like compounds
por: Zhang, Linlin, et al.
Publicado: (2021)

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2020)

A graph-based approach to construct target-focused libraries for virtual screening
por: Naderi, Misagh, et al.
Publicado: (2016)

ProBiS H2O MD Approach for Identification of Conserved Water Sites in Protein Structures for Drug Design‡
por: Jukič, Marko, et al.
Publicado: (2020)

Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
por: Gentile, Davide, et al.
Publicado: (2020)

Fenoterol and dobutamine as SARS-CoV-2 main protease inhibitors: A virtual screening study
por: Bolelli, Kayhan, et al.
Publicado: (2021)

High Throughput Virtual Screening to Discover Inhibitors of the Main Protease of the Coronavirus SARS-CoV-2
por: Olubiyi, Olujide O., et al.
Publicado: (2020)

Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening
por: Hakami, Abdulrahim R, et al.
Publicado: (2021)

Machine Learning in Antibacterial Drug Design
por: Jukič, Marko, et al.
Publicado: (2022)

Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors
por: Roy, David M, et al.
Publicado: (2014)

Virtual Screening of Artemisia annua Phytochemicals as Potential Inhibitors of SARS-CoV-2 Main Protease Enzyme
por: Miandad, Khalid, et al.
Publicado: (2022)

Molecular Dynamics Simulations Reveal Interactions of an IgG1 Antibody With Selected Fc Receptors
por: Kralj, Sebastjan, et al.
Publicado: (2021)

Pharmacophore based virtual screening for natural product database revealed possible inhibitors for SARS-COV-2 main protease
por: El-Ashrey, Mohamed K., et al.
Publicado: (2022)

Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M(pro) Protease through Virtual Screening
por: Rubio-Martínez, Jaime, et al.
Publicado: (2021)

Virtual Screening of Indonesian Herbal Database as HIV-1 Protease Inhibitor
por: Yanuar, Arry, et al.
Publicado: (2014)

Towards discovery of inhibitors of the undecaprenyl-pyrophosphate phosphatase BacA by virtual high-throughput screening
por: Jukič, Marko, et al.
Publicado: (2022)

Biochemical screening for SARS-CoV-2 main protease inhibitors
por: Coelho, Camila, et al.
Publicado: (2020)

Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib
por: Goldberg, Alyse S, et al.
Publicado: (2012)

High Throughput Screening of Protease Inhibitor Libraries Using a Novel Dual Pseudotype-Based Assay for SARS-CoV Entry
por: Zhou, Yanchen, et al.
Publicado: (2009)

An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library
por: Li, Shuhua G., et al.
Publicado: (2022)

Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library
por: Liu, Nanxin, et al.
Publicado: (2023)

A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen
por: Roof, Rebecca A, et al.
Publicado: (2009)

Identification of Selective Inhibitors of the Plasmodium falciparum Hexose Transporter PfHT by Screening Focused Libraries of Anti-Malarial Compounds
por: Ortiz, Diana, et al.
Publicado: (2015)

Mimicking Strategy for Protein–Protein Interaction Inhibitor Discovery by Virtual Screening
por: Wu, Ke-Jia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4cqida27qc3oqjrhl062qa441h